Pancreatic cancer drug not recommended People with pancreatic cancer have very limited treatment options. HIgh costs of pegylated liposomal irinotecan means it is too expensive to recommend. said NICE (National Institute for Health and Care Excellence) as given in their draft guidance not recommending pegylated liposomal irinotecan also called nal-iri, Onivyde and made by Shire),…
